Mark Przybylowski

1.7k total citations
6 papers, 303 citations indexed

About

Mark Przybylowski is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Mark Przybylowski has authored 6 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Mark Przybylowski's work include Virus-based gene therapy research (4 papers), CAR-T cell therapy research (3 papers) and CRISPR and Genetic Engineering (2 papers). Mark Przybylowski is often cited by papers focused on Virus-based gene therapy research (4 papers), CAR-T cell therapy research (3 papers) and CRISPR and Genetic Engineering (2 papers). Mark Przybylowski collaborates with scholars based in United States. Mark Przybylowski's co-authors include Michel Sadelain, Isabelle Rivière, Shirley Bartido, Oriana Bórquez-Ojeda, Daniel Hollyman, Malgorzata Olszewska, Clare Taylor, Renier J. Brentjens, Raymond Yeh and Jolanta Stefanski and has published in prestigious journals such as Journal of Clinical Oncology, Vaccine and Gene Therapy.

In The Last Decade

Mark Przybylowski

6 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Przybylowski United States	5	239	144	123	102	74	6	303
Minnal Gupta United States	7	255 1.1×	97 0.7×	114 0.9×	84 0.8×	73 1.0×	9	309
Shiwani Agarwal Germany	7	273 1.1×	135 0.9×	124 1.0×	158 1.5×	86 1.2×	7	359
Nadine Mockel-Tenbrinck Germany	8	263 1.1×	135 0.9×	72 0.6×	225 2.2×	92 1.2×	11	405
Jamal Alzubi Germany	11	199 0.8×	290 2.0×	122 1.0×	129 1.3×	56 0.8×	20	452
Angela Hückelhoven‐Krauss Germany	13	333 1.4×	131 0.9×	120 1.0×	111 1.1×	112 1.5×	26	403
Vincent Allain France	9	231 1.0×	179 1.2×	99 0.8×	81 0.8×	52 0.7×	22	388
Jessica Perazzelli United States	6	364 1.5×	190 1.3×	129 1.0×	120 1.2×	134 1.8×	9	425
Hannah Karlsson Sweden	6	393 1.6×	133 0.9×	159 1.3×	134 1.3×	107 1.4×	11	435
Diana Gumber United States	4	217 0.9×	96 0.7×	53 0.4×	104 1.0×	71 1.0×	6	280
Felipe Bedoya United States	8	324 1.4×	248 1.7×	116 0.9×	210 2.1×	120 1.6×	14	495

Countries citing papers authored by Mark Przybylowski

Since Specialization

Citations

This map shows the geographic impact of Mark Przybylowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Przybylowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Przybylowski more than expected).

Fields of papers citing papers by Mark Przybylowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Przybylowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Przybylowski. The network helps show where Mark Przybylowski may publish in the future.

Co-authorship network of co-authors of Mark Przybylowski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Przybylowski. A scholar is included among the top collaborators of Mark Przybylowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Przybylowski. Mark Przybylowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hollyman, Daniel, Jolanta Stefanski, Mark Przybylowski, et al.. (2009). Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy. Journal of Immunotherapy. 32(2). 169–180. 234 indexed citations

2.

Olszewska, Malgorzata, et al.. (2008). Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring γ-retrovirus-encoded hsvtk suicide genes. Gene Therapy. 15(21). 1454–1459. 3 indexed citations

3.

Hollyman, Daniel, Michael Weiss, Mark Przybylowski, et al.. (2008). A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19. Journal of Clinical Oncology. 26(15_suppl). 3045–3045. 4 indexed citations

4.

Przybylowski, Mark, Shirley Bartido, Oriana Bórquez-Ojeda, Michel Sadelain, & Isabelle Rivière. (2007). Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies. Vaccine. 25(27). 5013–5024. 25 indexed citations

5.

Budak-Alpdoǧan, Tülin, Mark Przybylowski, Mithat Gönen, et al.. (2006). Functional Assessment of the Engraftment Potential of Gammaretrovirus-Modified CD34 ⁺ Cells, Using a Short Serum-Free Transduction Protocol. Human Gene Therapy. 17(7). 780–794. 8 indexed citations

6.

Przybylowski, Mark, et al.. (2005). Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories. Gene Therapy. 13(1). 95–100. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact